CVD Risk Factors Tied to Cognitive Impairment in Schizophrenia
THURSDAY, March 4, 2021 -- Cardiovascular risk factors are associated with cognitive impairment among individuals with schizophrenia, according to a review and meta-analysis published online March 3 in JAMA Psychiatry.
Katsuhiko Hagi, Ph.D., from Sumitomo Dainippon Pharma in Tokyo, and colleagues conducted a systematic review and meta-analysis to examine the association between risk factors for cardiovascular disease (CVD) and cognition in individuals with schizophrenia. Data were included from 27 studies with 10,174 individuals with schizophrenia.
The researchers found that patients with schizophrenia who had metabolic syndrome, diabetes, or hypertension had significantly greater global cognitive deficits; nonsignificantly greater deficits were seen in patients with obesity, overweight, and insulin resistance. When analyzing cognitive subdomains, cardiovascular risk factors were associated with cognitive dysfunction in five domains for diabetes and in four domains for metabolic syndrome and hypertension.
"In individuals with CVD risk factors, cognitive impairment should be detected, and CVD risk factors and cognition should be managed," the authors write. "Additionally, accumulation or worsening of CVD risk factors should be prevented as much as possible, choosing psychotropic medications with low risk to worsen CVD risk factors and cognition, and promoting healthy lifestyle behaviors."
Several authors disclosed financial ties to pharmaceutical companies, including Sumitomo Dainippon Pharma, which funded the study.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
WEDNESDAY, April 14, 2021 -- Insomnia is associated with suicidal ideation, recent suicide attempt, and greater psychopathology in schizophrenia, according to a study published in...
TUESDAY, April 13, 2021 -- Higher leisure-time physical activity is associated with reduced major adverse cardiovascular events (MACE) and all-cause mortality risk, while higher...
TUESDAY, April 13, 2021 -- Twice-weekly fish intake is associated with a lower risk for major cardiovascular disease (CVD) and mortality in patients with prior CVD, but not the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.